Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1949 1
1951 2
1952 1
1956 2
1968 1
1974 1
1979 1
1985 1
1986 2
1987 1
1989 1
1990 3
1991 1
1992 1
1993 3
1994 1
1995 2
1997 1
1998 3
1999 4
2001 3
2002 2
2003 4
2004 1
2005 4
2006 1
2007 1
2008 4
2009 4
2010 8
2011 7
2012 7
2013 4
2014 2
2015 5
2016 3
2017 4
2018 3
2019 3
2020 6
2021 4
2022 3
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

111 results

Results by year

Filters applied: . Clear all
Page 1
Progesterone and breast.
Lamb CA, Fabris VT, Lanari C. Lamb CA, et al. Among authors: lanari c. Best Pract Res Clin Obstet Gynaecol. 2020 Nov;69:85-94. doi: 10.1016/j.bpobgyn.2020.04.001. Epub 2020 Apr 10. Best Pract Res Clin Obstet Gynaecol. 2020. PMID: 32349923 Review.
Targeting progesterone receptors in breast cancer.
Giulianelli S, Molinolo A, Lanari C. Giulianelli S, et al. Among authors: lanari c. Vitam Horm. 2013;93:161-84. doi: 10.1016/B978-0-12-416673-8.00009-5. Vitam Horm. 2013. PMID: 23810006 Review.
Antiprogestins in breast cancer treatment: are we ready?
Lanari C, Wargon V, Rojas P, Molinolo AA. Lanari C, et al. Endocr Relat Cancer. 2012 May 3;19(3):R35-50. doi: 10.1530/ERC-11-0378. Print 2012 Jun. Endocr Relat Cancer. 2012. PMID: 22351709 Review.
Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial.
Elía A, Saldain L, Vanzulli SI, Helguero LA, Lamb CA, Fabris V, Pataccini G, Martínez-Vazquez P, Burruchaga J, Caillet-Bois I, Spengler E, Acosta Haab G, Liguori M, Castets A, Lovisi S, Abascal MF, Novaro V, Sánchez J, Muñoz J, Belizán JM, Abba MC, Gass H, Rojas P, Lanari C. Elía A, et al. Among authors: lanari c. Clin Cancer Res. 2023 Mar 1;29(5):866-877. doi: 10.1158/1078-0432.CCR-22-2060. Clin Cancer Res. 2023. PMID: 36269797 Free PMC article.
Isoform specificity of progesterone receptor antibodies.
Fabris V, Abascal MF, Giulianelli S, May M, Sequeira GR, Jacobsen B, Lombès M, Han J, Tran L, Molinolo A, Lanari C. Fabris V, et al. Among authors: lanari c. J Pathol Clin Res. 2017 Oct 10;3(4):227-233. doi: 10.1002/cjp2.83. eCollection 2017 Oct. J Pathol Clin Res. 2017. PMID: 29085663 Free PMC article.
111 results